<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>ADRENOMIMETIKLAR VA ADRENOBLOKATORLAR</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Kibriyeva Maxfirat</mods:namePart><mods:namePart type="family">Abdurakhmonova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Sarayeva</mods:namePart><mods:namePart type="family">Shaxzoda</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Ushbu maqolada adrenomimetiklar, adrenoblokatorlar hamda gipotenziv vositalarning farmakologik xususiyatlari, ta’sir mexanizmlari, klinik qo‘llanilishi va zamonaviy tibbiyotdagi ahamiyati ilmiy manbalar asosida tahlil qilindi. Simpatik nerv tizimiga ta’sir qiluvchi ushbu preparatlar yurak-qon tomir tizimi kasalliklari, arterial gipertenziya, shok holatlari va boshqa patologik jarayonlarni davolashda keng qo‘llanilishi yoritildi. Maqolada α- va β-adrenoretseptorlar bilan o‘zaro ta’sir mexanizmlari, farmakodinamik va farmakokinetik xususiyatlari hamda nojo‘ya ta’sirlari muhokama qilindi. Shuningdek, zamonaviy gipotenziv vositalarning samaradorligi va ularning arterial bosimni nazorat qilishdagi o‘rni ilmiy adabiyotlar asosida baholandi. Tadqiqot natijalari ushbu preparatlarning klinik amaliyotdagi ahamiyatini tasdiqlaydi hamda ularni ratsional qo‘llash yurak-qon tomir asoratlarini kamaytirishda muhim ekanligini ko‘rsatadi.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2026-05-16</mods:dateIssued></mods:originInfo><mods:originInfo><mods:publisher>Research Science and Innovation House</mods:publisher></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>